BioWorld

Dec. 13, 2010

View Archived Issues

The Game of Risk: Mitigation, Funding, World Domination

The object of the military-themed board game might be total world domination, but in the biotech game of risk, just surviving can be tricky enough. Read More

Money Raised Year to Date

Read More

MMRC ASH Data Validate Better-Faster-Cheaper Trials

Read More

Cancer Drug Causes Cancer: Catastrophe or Minor Blip?

Read More

Money Raised By Biotech in 2010

Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Phase I Clinical Trials Update: November 2010

Read More

Phase II Clinical Trials Update: November 2010

Read More

Phase III Clinical Trials Update: November 2010

Read More

American Association for the Study of Liver Diseases

Read More

American College of Rheumatology

Read More

American Heart Association

Read More

European Organisation for Research and Treatment of Cancer

Read More

Non-U.S. Clinical Trials & Regulatory Actions: Nov. 2010

Read More

FDA Submissions, Approvals & Other Actions: Nov. 2010

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More